LILLIAN SHORES: Open Payments
NPI 1073538245 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 58 payments from 14 companies in 2025. Trend: 2023 $722 · 2024 $764 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $411 |
| PFIZER INC. | 6 | $92 |
| Phathom Pharmaceuticals, Inc. | 6 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Lilly USA, LLC | 3 | $50 |
| Novo Nordisk Inc | 2 | $38 |
| Madrigal Pharmaceuticals | 2 | $38 |
| Ardelyx, Inc. | 2 | $34 |
| GENZYME CORPORATION | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
Products named: RINVOQ, XELJANZ, DUPIXENT, VOQUEZNA, Linzess, SKYRIZI, Wegovy, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
